Clinical Trials Directory

Trials / Completed

CompletedNCT04474431

Correlation of VEGF-A and Fluid Balance in Septic Shock

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
103 (actual)
Sponsor
University Hospital, Rouen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

VEGF is a key molecule in the control of vascular permeability via interactions with the VEGF-receptor on the endothelial cell. Several authors reported plasma VEGF levels are elevated in sepsis shock and associated with increased mortality (1,2). In septic shock, the main elements of treatment are intravenous fluids, appropriate antibiotics and vasopressors. Some authors observed positive fluid balance is associated with increased mortality rates in patients (3,4). To the best of our knowledge, no studies have shown a correlation between VEGF levels and the fluid balance. The aim of our study was to determine the role of VEGF in capillary leakage and the positive fluid balance in septic shock.

Conditions

Interventions

TypeNameDescription
OTHEREvaluation of VEGF-A levels in patients with septic shock is positively correlated with a positive fluid balance.Evaluation of VEGF-A levels in patients with septic shock is positively correlated with a positive fluid balance.

Timeline

Start date
2019-12-24
Primary completion
2023-10-17
Completion
2023-10-17
First posted
2020-07-16
Last updated
2026-02-06

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04474431. Inclusion in this directory is not an endorsement.

Correlation of VEGF-A and Fluid Balance in Septic Shock (NCT04474431) · Clinical Trials Directory